ASHP and other associations urge Congress to pass legislation that will ease drug shortages
Executives with the American Society of Health-System Pharmacists and other groups are urging Congress to pass federal legislation to ease drug shortages in the United States. Read full article. |
|
 |
Do you tweet?
Follow Drug Topics on Twitter to get up-to-the-minute access to FDA approvals, industry news, and more!
Click Here |
 |
|
SAMHSA reports 10 years of trends in alcohol- and substance-abuse treatment
The United States Department of Health and Human Services division of Substance Abuse and Mental Health Services Administration has released a study examining trends of admissions to U.S. substance abuse treatment facilities of people aged 12 years and over, during the period from 1998 to 2008. Read full article. |
|
|
DT Blog
|
A discussion generated by Drug Topics’ readers, editorial staff, and advisory board
David Stanley, RPh |
Patient Counseling: Walking a tightrope
Read full article.
|
|
Study proves that even with increased drug costs, adherence will reduce overall health spending
A new study conducted by CVS Caremark and published in Health Affairs, found that among patients who had increased drug costs but were adherent with their medications, a “substantial medical savings as a result of reductions in hospitalization and emergency department use” was realized. Read full article. |
|
|
HHS brief examines factors affecting generic use and cost savings
With several blockbusters going off patent, Secretary Kathleen Sebelius of the U.S. Department of Health and Human Services asked the office of the Assistant Secretary for Planning and Evaluation to “examine barriers to and identify opportunities for increasing generic use.” Read full article. |
|
|
Generic competition on the horizon as many pharmaceutical companies face patent expirations
The impact of generic drugs — which now account for more than 70% of all prescriptions dispensed in the United States — will continue to increase as some of the world’s most-prescribed products lose their patent protection in 2011 and begin facing generic competition. Read full article. |
|
|
FDA OKs label update for etravirine
FDA has approved a label update to include a 200-mg formulation of etravirine (Intelence, Tibotec Therapeutics), a non-nucleoside reverse transcriptase inhibitor indicated for the treatment of HIV-1 in adults resistant to an NNRTI and other antiretroviral agents. Read full article. |
|
|
Pfizer launches dual-chamber syringe for patients with hemophilia
Pfizer Inc. recently launched a syringe that aims to help hemophilia patients lead active lives and take care of their condition faster and easier. Read full article.
|
|
|
|
NACDS Foundation announces winners of Pharmacy Student Scholarship Awards
The National Association of Chain Drug Stores Foundation announced the 2010 recipients of the NACDS Foundation Pharmacy Student Scholarship Awards. Read full article.
|
|
OTC Product News
In this section we showcase products and product news that ran up against space limitations or fell outside the parameters of recently featured categories in the print edition. Look for more OTC Product News in upcoming issues of the Drug Topics e-newsletter. Read full article.
|
|
Merck halts vorapaxar study over bleeding concerns in stroke victims
Concern that its drug vorapaxar, in trial for its potential to prevent clots, actually increased the risk of bleeding in stroke victims has prompted Merck & Co. to halt a late-stage study of the drug, the Associated Press reported. Read full article.
|
|
FDA sends complete response letter to MannKind regarding new inhaler
FDA has sent MannKind Corp. a complete response letter regarding the company's New Drug Application for Afrezza (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with types 1 and 2 diabetes for the control of hyperglycemia. Read full article. |
|
Meetings and Events
February 6-8, 2011 NACDS Regional Chain Conference
Naples, FL
Contact:
P.O. Box 34814
Alexandria, Virginia 22334-0814
703-837-4300
February 13, 2011 19th Annual WILLIAM R. BACON MEMORIAL Breakfast
6:30 a.m. - 8:45 a.m.
Palm Springs, CA
Contact:
800-333-7535; 760-325-6611
[email protected]
March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
[email protected]
March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734
|
